Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2026 ,inter alia, to consider and approve As per Attachment

CIN: L24200MH1987PLC043427 Registered Office: G2 & G3, Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai - 400099; Tel: 22618452/22661541; Tel/Fax: 22618327; Email Id: bacilpha@yahoo.com/ bacilpharma07@gmail.com; Website: www.bacilpharma.com Date: 23/06/2026 The General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 524516 Subject: Intimation of Board Meeting pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of Bacil Pharma Limited is scheduled to be held on Friday, 26th June, 2026 at the Registered Office of the Company, inter alia, to consider and evaluate proposals for raising funds by the Company through one or more permissible modes, subject to such statutory and regulatory approvals as may be required, including but not limited to:  Preferential Issue (including preferential allotment of equity shares and/or convertible securities);  Rights Issue;  Any other permissible mode or combination thereof, as may be considered appropriate by the Board, in accordance with the applicable provisions of the Companies Act, 2013, the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable laws. The Board may also consider and transit any other business, if any, which may be placed before the Board with the permission of the Chairman. Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading read with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today until 48 hours after the declaration of the outcome of the Board Meeting, if applicable. The outcome of the Board Meeting shall be intimated to the Stock Exchange in accordance with the applicable provisions of the SEBI Listing Regulations. Kindly take the above information on record. Thanking You, Yours faithfully, For Bacil Pharma Limited Mrs. Chaitali Kalpataru Shah Director & CFO DIN: 11167778